CAR-NK cell therapies are innovative therapeutic options developed for the purpose of overcoming some of the limitations associated with CAR-T cell therapies, such as therapy-induced side effects.
Natural killer (NK) cells are pivotal in the innate immune response against cancer and viral infections, with their presence in tumors correlating to better patient outcomes in various cancers.